 Diagnosis, Precentage in Top Five
acute epstein-barr virus infection (mononucleosis), 0.02
acute lymphoblastic leukemia (all), 0.2
acute rheumatic fever, 0.12
addison's disease, 0.06
adrenal insufficiency (addison's disease), 0.02
allergic reaction, 0.24
allergic reaction (such as to medication or environmental factors), 0.02
allergic reaction or atopic dermatitis, 0.02
allergic reaction or contact dermatitis, 0.08
allergic reaction or dermatitis, 0.08
amyloidosis, 0.02
amyopathic dermatomyositis, 0.02
anemia, 0.16
anorexia nervosa, 0.06
asthma, 0.02
atopic dermatitis, 0.08
atopic dermatitis (eczema), 0.04
atopic dermatitis with myopathy, 0.02
atopic dermatitis with secondary infection, 0.02
celiac disease, 0.9
chronic fatigue syndrome, 0.04
chronic inflammatory demyelinating polyneuropathy (cidp), 0.02
chronic kidney disease, 0.02
congenital myasthenic syndrome, 0.02
congenital myasthenic syndromes, 0.02
congenital myopathy, 0.02
contact dermatitis, 0.04
cushing's syndrome, 0.44
cutaneous porphyria, 0.02
cyanotic congenital heart disease, 0.02
dermatomyositis, 1.38
dermatomyositis-like drug reaction, 0.02
duchenne muscular dystrophy, 0.02
eczema, 0.02
eczema with neuromuscular disorder, 0.02
ehlers-danlos syndrome, 0.6
ehlers-danlos syndrome (eds), 0.02
eosinophilic esophagitis, 0.16
eosinophilic fasciitis, 0.02
erythema infectiosum (fifth disease), 0.04
erythema multiforme, 0.4
erythropoietic protoporphyria, 0.06
esophageal dysphagia, 0.04
esophageal stricture, 0.04
fibromyalgia, 0.02
fifth disease (erythema infectiosum), 0.1
fifth disease (parvovirus b19 infection), 0.16
fifth disease (parvovirus b19), 0.04
gastroesophageal reflux disease (gerd), 0.02
guillain-barré syndrome, 0.02
henoch-schönlein purpura, 1.72
henoch-schönlein purpura (hsp), 2.38
henoch-schönlein purpura (iga vasculitis), 0.06
hyper-igd syndrome, 0.02
hyperthyroidism, 0.02
hypokalemic periodic paralysis, 0.02
hypothyroidism, 4.54
infectious mononucleosis, 0.48
infective endocarditis, 0.06
inflammatory bowel disease (ibd), 0.02
iron deficiency anemia, 0.14
iron-deficiency anemia, 0.02
juvenile arthritis, 0.02
juvenile dermatomyositis, 18.01
juvenile dermatomyositis (jdm), 0.08
juvenile idiopathic arthritis, 1.62
juvenile idiopathic arthritis (jia), 2.52
juvenile idiopathic arthritis (jia) with systemic features, 0.02
juvenile idiopathic arthritis (jia) with systemic involvement, 0.02
juvenile idiopathic arthritis (jia) with systemic onset, 0.12
juvenile idiopathic arthritis (systemic onset), 0.04
juvenile idiopathic arthritis (with systemic onset), 0.06
juvenile idiopathic arthritis with systemic features, 0.04
juvenile myasthenia gravis, 0.04
juvenile rheumatoid arthritis, 0.04
juvenile rheumatoid arthritis (jra), 0.06
juvenile systemic lupus erythematosus (jsle), 0.02
kawasaki disease, 6.63
langerhans cell histiocytosis, 0.08
leukemia, 0.52
lichen planus, 0.02
localized scleroderma, 0.04
localized scleroderma (morphea), 0.02
lupus (systemic lupus erythematosus), 0.48
lupus erythematosus, 0.06
lyme disease, 0.4
lymphadenitis, 0.02
lymphatic obstruction or lymphadenopathy, 0.02
lymphoma, 0.42
malabsorption syndrome (e.g., celiac disease), 0.02
malnutrition, 0.02
malnutrition or chronic illness, 0.02
mitochondrial myopathy, 0.02
mixed connective tissue disease, 9.87
mixed connective tissue disease (mctd), 3.46
mononucleosis, 0.02
muscular dystrophy, 0.5
myasthenia gravis, 0.4
nutritional deficiency (e.g., vitamin c deficiency or scurvy), 0.02
nutritional deficiency (e.g., vitamin c or d), 0.02
nutritional deficiency (e.g., vitamin d or c), 0.02
nutritional deficiency (such as vitamin c deficiency), 0.02
nutritional deficiency or malnutrition, 0.02
paraneoplastic syndrome, 0.02
parvovirus b19 infection, 0.02
parvovirus b19 infection (fifth disease), 0.1
pediatric allergic reaction, 0.02
pediatric lupus, 0.02
pediatric mixed connective tissue disease, 0.02
pediatric rheumatoid arthritis, 0.02
pediatric systemic lupus erythematosus (psle), 0.02
pediatric vasculitis, 0.06
peptic ulcer disease, 0.02
photosensitive eczema, 0.02
photosensitivity dermatitis, 0.04
photosensitivity due to medication or chemical exposure, 0.02
photosensitivity-related dermatitis, 0.02
polyarteritis nodosa, 0.04
polyarticular juvenile idiopathic arthritis, 0.02
polymorphic light eruption, 0.02
polymorphous light eruption, 0.04
polymyositis, 4.46
porphyria, 0.06
psoriasis, 0.12
psoriasis or psoriatic arthritis, 0.02
psoriasis with psoriatic arthritis, 0.02
psoriasis with secondary myopathy, 0.02
psoriatic arthritis, 0.7
psoriatic juvenile idiopathic arthritis, 0.04
raynaud's disease, 0.04
raynaud's phenomenon, 1.24
raynaud's phenomenon associated with an autoimmune condition, 0.02
raynaud's phenomenon secondary to a connective tissue disorder, 0.02
raynaud's phenomenon secondary to an autoimmune condition, 0.04
raynaud's phenomenon secondary to another autoimmune condition, 0.02
raynaud's phenomenon secondary to another condition, 0.02
raynaud's phenomenon secondary to autoimmune disease, 0.04
raynaud's phenomenon secondary to autoimmune disorder, 0.02
raynaud's phenomenon secondary to connective tissue disease, 0.04
raynaud's phenomenon with connective tissue disorder, 0.02
raynaud's phenomenon with secondary cause, 0.02
raynaud's phenomenon with secondary connective tissue disorder, 0.02
raynaud’s disease, 0.02
reactive arthritis, 0.02
rheumatic fever, 2.32
rheumatoid arthritis, 0.5
rheumatoid arthritis (juvenile form), 0.06
rheumatoid arthritis (juvenile idiopathic arthritis - jia), 0.02
rheumatoid arthritis (juvenile idiopathic arthritis), 0.26
rheumatoid arthritis (juvenile), 0.08
rheumatoid arthritis with skin manifestations, 0.02
sarcoidosis, 0.1
scarlet fever, 0.3
scleroderma, 2.8
scleroderma (juvenile systemic sclerosis), 0.02
scleroderma (localized or systemic), 0.02
scleroderma (localized), 0.02
scleroderma (systemic sclerosis), 0.02
scorbutic (vitamin c deficiency), 0.02
scurvy, 0.1
scurvy (vitamin c deficiency), 0.02
sjogren's syndrome, 0.02
sjögren's syndrome, 1.08
sjögren’s syndrome, 0.06
spinal muscular atrophy, 0.02
staphylococcal scalded skin syndrome (ssss), 0.04
still's disease (a form of systemic jia), 0.02
strep throat with scarlet fever, 0.02
systemic juvenile idiopathic arthritis, 0.48
systemic juvenile idiopathic arthritis (sjia), 0.24
systemic lupus erythematosus, 1.18
systemic lupus erythematosus (sle), 18.05
systemic sclerosis, 0.02
systemic sclerosis (scleroderma), 0.02
thyroid dysfunction (e.g., hashimoto's thyroiditis), 0.02
vasculitis, 0.24
viral exanthem, 0.58
viral exanthem with arthritis, 0.02
viral exanthem with myositis, 0.1
viral exanthema, 0.26
viral exanthema (e.g., parvovirus b19), 0.02
viral exanthema with myositis, 0.02
viral infection (e.g., ebv or parvovirus), 0.02
viral infection (e.g., epstein-barr virus or cytomegalovirus), 0.02
viral infection (e.g., epstein-barr virus), 0.2
viral infection (e.g., parvovirus b19), 0.02
viral infection with autoimmune features, 0.04
viral infection with complications, 0.02
viral infection with dermatitis, 0.02
viral infection with myositis, 0.04
viral infection with raynaud's phenomenon, 0.02
viral infection with reactive arthritis, 0.02
viral myositis, 0.66
vitamin b12 deficiency, 0.02
vitamin c deficiency (scurvy), 0.22
vitamin d deficiency, 0.36
vitamin deficiency (e.g., vitamin c or d), 0.02
wilson's disease, 0.02
